A commercial elisa method for identifying type 2N von Willebrand disease patients and carriers

被引：0
作者：
Casonato, A. [1 ]
Pontara, E. [1 ]
Sartorello, F. [1 ]
Cattini, M. G. [1 ]
Daidone, V [1 ]
Casonato, A. [1 ]
机构：
[1] Univ Padua, Sch Med, Dept Cardiol Thorac & Vasc Sci, I-35100 Padua, Italy
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-TH-569
引用
收藏
页码：946 / 946
页数：1
相关论文
共 50 条
  • [31] Spontaneous hemarthrosis in combined Glanzmann thrombasthenia and type 2N von Willebrand disease
    Pontara, Elena
    Gresele, Paolo
    Cattini, Maria Grazia
    Daidone, Viviana
    Barbon, Giovanni
    Girolami, Antonio
    Zanon, Ezio
    Casonato, Alessandra
    BLOOD COAGULATION & FIBRINOLYSIS, 2014, 25 (04) : 401 - 404
  • [32] Evaluation of FVIII binding activity in type 2N von Willebrand's disease
    Sajan, F.
    Short, P. E.
    Guilliatt, A. M.
    Williams, M. D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 : 78 - 79
  • [33] Type 2N von Willebrand disease - 10 years of diagnostic experience in France
    Mazurier, C
    HAEMOPHILIA, 2000, 6 : 26 - 26
  • [34] Characterisation of type 2N von Willebrand disease using phenotypic and molecular techniques
    Nesbitt, IM
    Goodeve, AC
    Guilliatt, AM
    Makris, M
    Preston, FE
    Peake, IR
    THROMBOSIS AND HAEMOSTASIS, 1996, 75 (06) : 959 - 964
  • [35] Expression of two type 2N von Willebrand disease mutations identified in exon 18 of von Willebrand factor gene
    Hilbert, L
    Jorieux, S
    Fontenay-Roupie, M
    Guicheteau, M
    Fressinaud, E
    Meyer, D
    Mazurier, C
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 127 (02) : 184 - 189
  • [36] Mutations on cysteine residues 25 and 95 of mature von Willebrand factor induce type 2N von Willebrand disease
    Jorieux, S
    Gaucher, C
    Fressinaud, E
    Goudemand, J
    Meyer, D
    Mazurier, C
    THROMBOSIS AND HAEMOSTASIS, 1997, : O1586 - O1586
  • [37] Clinical phenotype in genetically confirmed von Willebrand disease type 2N patients reflects a haemophilia A phenotype
    van Meegeren, M. E. R.
    Mancini, T. L.
    Schoormans, S. C. M.
    van Haren, B. J. T.
    van Duren, C.
    Diekstra, A.
    Laros-van Gorkom, B. A. P.
    Brons, P. P. T.
    Simons, A.
    Hoefsloot, L.
    van Heerde, W. L.
    HAEMOPHILIA, 2015, 21 (05) : E375 - E383
  • [38] Solution structure and dynamics of the major FVIII binding region on von Willebrand factor: implications for type 2N von Willebrand disease
    Shiltagh, N.
    Kirkpatrick, J.
    Cabrita, L. D.
    Thalassinos, K.
    Tuddenham, G. D.
    Hansen, D. F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 13 - 13
  • [39] Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice
    Swystun, L. L.
    Georgescu, I.
    Mewburn, J.
    Deforest, M.
    Nesbitt, K.
    Hebert, K.
    Dwyer, C.
    Brown, C.
    Notley, C.
    Lillicrap, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (08) : 1607 - 1619
  • [40] Modification of factor VIII-von Willebrand factor binding activity assay for diagnosis of von Willebrand disease type 2N
    Zhukov, O. S.
    Popov, J.
    Ramos, R.
    Huebner, A.
    Ruden, S.
    Sferruzza, A.
    Dlott, J.
    Sahud, M.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A139 - A139
12345